Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

被引：1
|
作者：
Borgoyakova, M. B. [1 ]
Karpenko, L. I. [1 ]
Merkulyeva, I. A. [1 ]
Shcherbakov, D. N. [1 ]
Rudometov, A. P. [1 ]
Starostina, E. V. [1 ]
Shanshin, D. V. [1 ]
Isaeva, A. A. [1 ]
Nesmeyanova, V. S. [1 ]
Volkova, N. V. [1 ]
Belenkaya, S. V. [1 ]
Volosnikova, E. A. [1 ]
Zadorozhny, A. M. [1 ]
Orlova, L. A. [1 ]
Zaykovskaya, A. V. [1 ]
Pyankov, O. V. [1 ]
Bazhan, S. I. [1 ]
Ilyichev, A. A. [1 ]
机构：
[1] Fed Serv Oversight Consumer Protect & Welf, State Res Ctr Virol & Biotechnol VECTOR, Koltsov, Novosibirsk Reg, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2022年 / 174卷 / 02期
关键词：
SARS-CoV-2; DNA vaccines; subunit vaccines; DNA; protein vaccines; immune response;
D O I：
10.1007/s10517-023-05682-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
During the COVID-19 pandemic, the development of prophylactic vaccines, including those based on new platforms, became highly relevant. One such platform is the creation of vaccines combining DNA and protein components in one construct. For the creation of DNA vaccine, we chose the full-length spike protein (S) of the SARS-CoV-2 virus and used the recombinant receptor-binding domain (RBD) of the S protein produced in CHO-K1 cells as a protein component. The immunogenicity of the developed combined vaccine and its individual components was compared and the contribution of each component to the induction of the immune response was analyzed. The combined DNA/protein vaccine possesses the advantages of both underlying approaches and is capable of inducing both humoral (similar to subunit vaccines) and cellular (similar to DNA vaccines) immunity.
引用
收藏
页码：246 / 249
页数：4
相关论文
共 50 条
  • [21] Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
    Nurpeisova, Ainur
    Khairullin, Berik
    Abitaev, Ruslan
    Shorayeva, Kamshat
    Jekebekov, Kuanish
    Kalimolda, Elina
    Kerimbayev, Aslan
    Akylbayeva, Karligash
    Abay, Zhandos
    Myrzakhmetova, Balzhan
    Nakhanov, Aziz
    Absatova, Zharkinay
    Nurabayev, Sergazy
    Orynbayev, Mukhit
    Assanzhanova, Nurika
    Abeuov, Khairulla
    Kutumbetov, Lespek
    Kassenov, Markhabat
    Abduraimov, Yergaly
    Zakarya, Kunsulu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [22] Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
    Capone, Stefania
    Raggioli, Angelo
    Gentile, Michela
    Battella, Simone
    Lahm, Armin
    Sommella, Andrea
    Contino, Alessandra Maria
    Urbanowicz, Richard A.
    Scala, Romina
    Barra, Federica
    Leuzzi, Adriano
    Lilli, Eleonora
    Miselli, Giuseppina
    Noto, Alessia
    Ferraiuolo, Maria
    Talotta, Francesco
    Tsoleridis, Theocharis
    Castilletti, Concetta
    Matusali, Giulia
    Colavita, Francesca
    Lapa, Daniele
    Meschi, Silvia
    Capobianchi, Maria
    Soriani, Marco
    Folgori, Antonella
    Ball, Jonathan K.
    Colloca, Stefano
    Vitelli, Alessandra
    MOLECULAR THERAPY, 2021, 29 (08) : 2412 - 2423
  • [23] Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
    Ford, Bart N.
    Savitz, Jonathan
    IMMUNITY & AGEING, 2022, 19 (01)
  • [24] Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
    Sparks, Jeffrey A.
    Tedeschi, Sara K.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (09): : 813 - 815
  • [25] The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
    Yang, Lei
    Liu, YaMing
    Guo, Qiao
    Jiang, DePeng
    OPEN MEDICINE, 2023, 18 (01):
  • [26] Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
    Bart N. Ford
    Jonathan Savitz
    Immunity & Ageing, 19
  • [27] The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
    Mazarakis, Nadia
    Toh, Zheng Quan
    Neal, Eleanor
    Bright, Kathryn
    Luu, Skyy
    Quah, Leanne
    Ng, Yan Yung
    Nguyen, Cattram
    Hart, John
    Do, Lien Anh Ha
    Rudel, Anna
    Dassanayake, Shashini
    Higgins, Rachel A.
    Ong, Darren Suryawijaya
    Justice, Fran
    Moore, Kerryn A.
    Watts, Emma
    Mahanty, Siddhartha
    Subbarao, Kanta
    Mulholland, Kim
    von Mollendorf, Claire
    V. Licciardi, Paul
    JOURNAL OF INFECTION, 2025, 90 (03)
  • [28] BCG Vaccine Not Effective Against COVID-19
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (20): : 1730 - 1730
  • [29] Offline: Preparing for a vaccine against COVID-19
    Horton, Richard
    LANCET, 2020, 396 (10246): : 226 - 226
  • [30] Challenges in the Development of a Vaccine Against COVID-19
    Chen, Wei
    Zhu, Feng-Cai
    ENGINEERING, 2020, 6 (10) : 1067 - 1069
12345